In the searching for the hepatoprotective agents from natural sources, it is important that relevant models of human liver toxicosis are used in order to identify agents with therapeutic potential. Liver toxicity induced by the chemicals and drugs has been recognized as a toxicological problem for a long time. Some of drugs are given for prolonged period of time and in high doses lead to the serious clinical concern. Therefore, it is valuable to use the hepatotoxic agents that are more relevant to human liver toxicosis such as some drugs with liver toxic effect as their adverse effect. Tacrine (1,2,3,4-tetrahydro-9-aminoacridine hydrochloride) is the one of such category of drugs. Tacrine is an acetylcholinesterase inhibitor that is approved for the treatment of Alzheimer's disease. However, tacrine treatment for Alzheimer's disease results in reversible hepatotoxicity in 30-50% of patients, which seriously limits its clinical use. 1) Accordingly, the identification of constituents in natural products that have protective effects on tacrine-induced hepatotoxicity would be valuable. In the present study, an immortalized human hepatoma cell line, Hep G2 was employed to screen for agents that protect against tacrine-induced hepatotoxicity. This cell-line was chosen because it retains many cellular functions often lost by primary hepatocytes, e.g., the expression of hepatocyte-specific cell surface receptors and the synthesis and secretion of plasma proteins.
2) During the course of our continuing screening studies [3] [4] [5] [6] [7] for natural hepatoprotective agents, we found that the CHCl 3 -soluble fraction of the MeOH extract of the root barks of Cudrania tricuspidata BUREAU (Moraceae), which is one of the traditional Chinese medicines used for the treatment of lumbago, hemoptysis, and contusion, 8) showed promising hepatoprotective activity. We describe the isolation and identification of the hepatoprotective constituents in C. tricuspidata root barks. Instruments Optical rotation was measured on a JASCO DIP-370 digital polarimeter. UV spectra were obtained on a Milton Roy 3000 spectrometer. NMR spectra were recorded using a JEOL Eclipse-500 MHz spectrometer (500 MHz for 1 H and 125 MHz for The dried and pulverized root barks of C. tricuspidata (4 kg) were extracted twice with hot MeOH (20 l) for 2 h. The MeOH extract (168 g) was partitioned between equal volumes of n-hexane and 60% aqueous MeOH, and the aqueous MeOH layer extracted subsequently with CHCl 3 . Finally, the 60% aqueous MeOH mixtures was evaporated in vacuo and partitioned between n-BuOH and H 2 O. A portion (35 g) of hepatoprotective CHCl 3 -soluble fraction (53.3 g) was chromatographed on silica gel column (6.5ϫ60 cm) using 80% aqueous MeOH) to furnish compound 2 (8.6 mg). Fr. B (330 mg) was chromatographed on a silica column (3.0ϫ 30 cm, eluent; CH 2 Cl 2 /MeOH) to yield three subfractions (Fr. B1-B3). Fr. B1 (70 mg) was further chromatographed on silica gel (2.0ϫ30 cm) using n-hexane/EtOAc (4 : 1) to yield compound 3 (20.1 mg). Fr. B2 (150 mg) was subjected to RP C-18 column (2.0ϫ30 cm) chromatography (eluent; 65% aqueous MeOH) to obtain compound 4 (28.0 mg). Fr. B3 (100 mg) was repeatedly chromatographed on silica gel column (2.0ϫ30 cm, eluent; n-hexane/EtOAc, 4 : 1) to give compound 5 (35.4 mg) and compound 6 (41.6 mg). Fr. C (238 mg) was subjected to silica gel column (2.0ϫ30 cm) chromatography (eluent; CH 2 Cl 2 /MeOH) to obtain three subfractions (Fr. C1-C3). Fr. C2 (63.4 mg) was further chromatographed on silica gel column (2.0ϫ35 cm, eluent; nhexane/EtOAc, 4 : 1) to yield compound 7 (22.1 mg). Fr. C3 (50.8 mg) chromatographed on silica gel column (2.0ϫ 35 cm, eluent; n-hexane/EtOAc, 4 : 1) to give compound 8 (20.6 mg).
MATERIALS AND METHODS

Materials
In Vitro Assay of the Hepatoprotective Activity on Tacrine-Induced Cytotoxicity in Hep G2 Cells Tacrineinduced cytotoxicity assay was conducted using a minor modification of the method described by Song et al. 4) Briefly, human hepatoma Hep G2 cells from the American Type Culture Collection were maintained at 2ϫ10 5 cells/well in complete medium consisting of RPMI supplemented with 10% heat-inactivated FBS, penicillin G (100 IU/ml), and streptomycin (100 mg/ml), and then incubated at 37°C in a humidified atmosphere containing 5% CO 2 and 95% air. Cytotoxicity was assessed by MTT assay by incubating cells for 2 h in the corresponding medium in the presence of 1.2 mM tacrine. The samples were tested at four different concentrations (5, 10, 30, 50 mM) in triplicate. EC 50 values for hepatoprotective effects (defined as percentage viability versus the respective control) were calculated by linear regression using mean values, and are expressed as meansϮS.D. of three independent experiments. The results were compared using one-way ANOVA and Tukey's multiple comparison test. Statistically significant differences between groups were defined as having p values of Ͻ0.01. Calculations were performed using GraphPad Prism program (GraphPad Software, Inc., San Diego, CA, U.S.A.).
RESULTS AND DISCUSSION
In the present study, we investigated the MeOH extract of the root barks of C. tricuspidata with the aim of identifying natural hepatoprotective compounds. Of the MeOH extract fractions obtained during the course of the study, the CHCl 3 -soluble fraction was found to have a marked protective effect on Hep G2 cells treated with tacrine (protective ratio: 90.8% at 100 mg/ml). The subsequent bioassay-guided fractionation of this CHCl 3 -soluble fraction led to the isolation of eight compounds.
The structures of isolated compounds were identified as euchrestaflavanone C (1), 9) gerontoxanthone A (2), 10) cudraxanthone B (3), 11) cudraflavone B (4), 12) gericudranin E (5), 13) cudraxanthone C (7), 11) and cudraxanthone H (8), 14) respectively, by comparing UV, (Table 1) , including one carbonyl group, two aromatic rings with six oxygenated carbons, and two C 5 groups, corresponding to a diprenylated and tetrahydroxylated xanthone. The positions of the substituents on the ring system were determined on the basis of HMBC correlations, as shown in Table 1 . To our best knowledge, this is the first report on the isolation of isocudraxanthone K (compound 6).
Compounds 4 and 5 were found to have marked protective effects on tacrine-induced cytotoxicity in human liver-derived Hep G2 cells with the EC 50 values of 37.39Ϯ0.4 and 39.87Ϯ0.7 mM, respectively (Figs. 1A, B) , and compound 2 showed moderate hepatoprotective effect with an EC 50 value of 125.9Ϯ1.5 mM (Fig. 1C) . MTT assays were used as an indirect measure of cell viability. Moreover, compounds 2, 4, and 5 showed no cytotoxicity at concentrations of Ͻ50 mM (data not shown). Silybin, one of the most well-known hepatoprotective agents was used as a positive control, and had an EC 50 value of 84.76Ϯ0.5 mM. Although the mechanism underlying the hepatotoxicity of tacrine remains to be elucidated, it has been shown that tacrine alters intracellular glu-tathione concentrations in cultured hepatocytes, which suggests that its toxic effect involves reactive oxygen species and lipid peroxidation, 15) and that antioxidative compounds may protect against tacrine-induced hepatotoxicity. Therefore, we surmise that the observed hepatoprotective effects of compounds 2, 4, and 5 are related to their antioxidative activities, however, further studies are necessary to verify this and to elucidate the mechanistic bases for the hepatoprotective effects exerted by these compounds. Although the hepatoprotective effect of cudraflavone B (4) had been reported by our previous study, 6 ) the hepatoprotective effects of compounds 2 and 5 have not, to the best of our knowledge, been reported previously, which suggests that these compounds be further evaluated as potential hepatoprotective agents. 
